Literature DB >> 26670454

Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).

Dilek Solmaz1, Tulay Yildirim2, Okan Avci1, Nazmiye Tomas3, Servet Akar4.   

Abstract

Various types of disease activity measures are available for axial spondyloarthritis (axSpA), and there is no gold standard for all individual patients. The ankylosing spondylitis disease activity score (ASDAS) is highly discriminatory, sensitive to change, and associated with structural progression. A simplified version of the ASDAS (SASDAS) was proposed and found to be a simple and practical tool to assess disease activity. Our aim was to test the performance characteristics of the SASDAS and compare it with validated tools. In total, 97 consecutive ankylosing spondylitis (AS) patients were included in the study. Disease activity was assessed by the ASDAS-erythrocyte sedimentation rate (ESR), ASDAS-C-reactive protein (CRP), bath ankylosing spondylitis disease activity index (BASDAI), and SASDAS. The relationship among these activity indices and the level of agreement of various activity categories were tested. There was a strong correlation between the SASDAS and other activity indices, including the BASDAI (r = 0.916, p < 0.001), ASDAS-CRP (r = 0.847, p < 0.001), and ASDAS-ESR (r = 0.942, p < 0.001). Although the agreement between the ASDAS-ESR and SASDAS was good (weighted kappa of 0.744 and total agreement of 77 %), there was moderate agreement between the ASDAS-CRP and SASDAS (weighted kappa of 0.579 and total agreement of 66 %). The disagreement was particularly striking in "moderate" and "high disease activity" states. Approximately 40 % of patients classified as moderate activity according to the ASDAS-ESR and 45 % according to the ASDAS-CRP were differentially categorized by the SASDAS. The results of the present analysis suggest that the simplified version of the ASDAS-ESR should be further validated in various settings and populations due to a questionable level of agreement between the ASDAS-CRP and SASDAS.

Entities:  

Keywords:  Disease activity; Simplified version of the ASDAS (SASDAS)

Mesh:

Substances:

Year:  2015        PMID: 26670454     DOI: 10.1007/s10067-015-3147-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

Review 1.  How to measure disease activity in axial spondyloarthritis?

Authors:  Pedro Machado; Désirée van der Heijde
Journal:  Curr Opin Rheumatol       Date:  2011-07       Impact factor: 5.006

2.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.

Authors:  Gamze Kılıç; Erkan Kılıç; Kemal Nas; Murat Karkucak; Erhan Çapkın; Abdullah Zübeyir Dağlı; Remzi Çevik; Salih Özgöçmen
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

4.  Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?

Authors:  Lihi Eder; Vinod Chandran; Hua Shen; Richard J Cook; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2010-07-13       Impact factor: 19.103

5.  Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis.

Authors:  S Z Aydin; M Can; P Atagunduz; H Direskeneli
Journal:  Clin Exp Rheumatol       Date:  2010-10-22       Impact factor: 4.473

6.  A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.

Authors:  Fernando A Sommerfleck; Emilce E Schneeberger; Emilio E Buschiazzo; José A Maldonado Cocco; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2012-08-16       Impact factor: 2.980

Review 7.  Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis.

Authors:  Pedro M Machado; Siba P Raychaudhuri
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-07       Impact factor: 4.098

8.  Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.

Authors:  Marie Godfrin-Valnet; Clément Prati; Marc Puyraveau; Eric Toussirot; Hélène Letho-Gyselink; Daniel Wendling
Journal:  Joint Bone Spine       Date:  2013-03-01       Impact factor: 4.929

9.  Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.

Authors:  C Fernández-Espartero; E de Miguel; E Loza; E Tomero; M Gobbo; M A Descalzo; E Collantes-Estévez; J Mulero; S Muñoz-Fernández; P Zarco; L Carmona
Journal:  Ann Rheum Dis       Date:  2013-05-24       Impact factor: 19.103

10.  Ankylosing spondylitis functional and activity indices in clinical practice.

Authors:  C Popescu; M Trandafir; Am Bădică; F Morar; D Predeţeanu
Journal:  J Med Life       Date:  2014-03-25
View more
  3 in total

1.  SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.

Authors:  Emilce Edith Schneeberger; Natalia Zamora; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

2.  Exploring simplified disease activity indices in Ankylosing Spondylitis in different populations is the need of the hour.

Authors:  T G Sundaram; Latika Gupta
Journal:  Rheumatol Int       Date:  2021-02-16       Impact factor: 2.631

3.  Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.

Authors:  Nagma Bansal; Lalit Duggal; Neeraj Jain
Journal:  J Clin Diagn Res       Date:  2017-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.